Home > Boards > US OTC > Medical - Healthcare > Propanc Biopharma Inc. (PPCB)

Just another $1.99 increase in price and Nathanielsz

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
elkhunter Member Profile
 
Followed By 1
Posts 229
Boards Moderated 0
Alias Born 08/22/16
160x600 placeholder
Information Statements (revised) (prer14c) Edgar (US Regulatory) - 7/2/2020 3:58:20 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 6/26/2020 5:31:26 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 6/11/2020 3:25:08 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2020 4:46:23 PM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 5/13/2020 5:52:14 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 4/17/2020 4:16:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/3/2020 5:01:46 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 2/19/2020 6:01:23 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 2/18/2020 6:01:01 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/14/2020 5:49:06 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 2/6/2020 1:03:19 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/24/2020 5:12:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/17/2020 5:16:20 PM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 12/12/2019 5:50:16 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 5:09:49 PM
Annual Report (10-k) Edgar (US Regulatory) - 10/15/2019 5:42:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/8/2019 5:15:51 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 9/30/2019 2:28:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 4:46:19 PM
Withdrawal of Registration Statement (rw) Edgar (US Regulatory) - 8/21/2019 4:32:25 PM
Withdrawal of a Registration Statement Withdrawal Request (rw Wd) Edgar (US Regulatory) - 8/20/2019 5:30:41 PM
Withdrawal of Registration Statement (rw) Edgar (US Regulatory) - 8/19/2019 9:47:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2019 4:54:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/10/2019 5:01:15 PM
elkhunter   Monday, 05/18/20 11:54:07 AM
Re: None
Post # of 42052 
Just another $1.99 increase in price and Nathanielsz can apply to list to a major stock exchange. The last two reverse splits were so beneficial to the stockholders let have a few more.

The Board believes it will be beneficial to the stockholders if our Common Stock is traded on a recognized stock exchange, either The Nasdaq Capital Market or NYSE American (an “Exchange”). In the future we hope to apply to list our Common Stock on an Exchange as soon as we are eligible to do so following the consummation of the Reverse Stock Split, a future public capital raise and satisfaction of other listing requirements and conditions. The Nasdaq Capital Market for example has minimum bid price requirement for new applicants of $4.00 per share. However, a company may qualify under a closing price alternative of $3.00 or $2.00 if the company meets varying requirements.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist